Supplementary Table 1

Published: 20 January 2025| Version 1 | DOI: 10.17632/5tj8phdkj8.1
Contributor:
Joyce Kang

Description

Supplementary Table 1 for Kang & Nabel Smith et al. (JAAD, 2025). "Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis"

Files

Institutions

Brigham and Women's Hospital, Harvard Medical School, Massachusetts General Hospital

Categories

Dermatology, Rituximab, Systemic Sclerosis

Licence